ALLENTOWN, Pa. and CAMPBELL, Calif., May 25 /PRNewswire/ — HunterHeart offers
physicians and patients sophisticated risk characterization and
personalized therapy guidelines for cardiovascular disease.
HNL will be performing a battery of advanced tests, offering
an accompanying nutrition program, and wellness coaching.
Gerry Weiss, MD, Hunter’s Medical Director stated:
“With appropriate risk characterization and treatment,
cardiovascular disease can be prevented for many patients and MI
and stroke events can be significantly reduced.”
“HNL’s reputation for quality, service and innovation is
exceptional. Hunter is delighted to be working with HNL to
reduce cardiovascular disease in PA and NJ,” stated Chris Riedel, Hunter’s CEO. HNL’s
President and CEO, David G. Beckwith Ph.D., stated that, “The
HunterHeart program will assist our physicians in delivering
comprehensive cardiovascular health advice to their patients, and
establishes HNL as a center of excellence for preventive
cardiology.”
About Health Network Laboratories
Based in Allentown,
Pennsylvania, Health Network Laboratories (HNL) is a
multi-regional medical laboratory with technologically advanced
facilities in Pennsylvania and
New Jersey. HNL serves the
need of the public and health care communities performing almost 6
million clinical and pathology tests each year. HNL is
consistently rated highly by physicians and clients in all areas of
laboratory performance and customer satisfaction.
HNL offers a full complement of clinical laboratory and anatomic
pathology services, including highly spe
‘/>”/>
